Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)

Trends in antithrombotic management in patients with atrial fibrillation: a report from Polish participants in the EURObservational Research Programme – Atrial Fibrillation General Long-Term Registry

“…Almost 95% of patients with indications for anticoagu lation (CHA 2 DS 2 VASc ≥2) were taking at least 1 OAC, which suggests a better adherence to recom mendations for OAC, as compared with the above studies (ie, GARFIELD, 59.3%; Euro Heart, 67%; PREFER, 85.6% of eligible patients received OAC). 6-8 Compared with previous data from EORP AF Pi lot where 65% of Polish patients with indications (CHA 2 DS 2 VASc >2) and 67% of those without in dications (CHA 2 DS 2 VASc = 0) were prescribed OACs, 27 our results demonstrate a clear trend to wards more frequent OAC prescription. Also, APT was less frequently prescribed in patients at high risk of thromboembolic event (but still), as com pared with previous studies.…”

Incremental value of left atrial mechanical dispersion over CHA2DS2‐VASc score in predicting risk of thrombus formation

“…Atrial fibrillation (AF) is an increasing public health problem and affects up to 17% of patients aged 80 years or older . Evidence shows that patients at high risk for AF are undertreated with anticoagulation compared to overtreated low‐risk AF patients . Moreover, left atrial appendage thrombi (LAAT) or dense echo contrast is relatively common findings on transesophageal echocardiograms in patients receiving anticoagulants …”

Pharmacological stroke prevention in the elderly with atrial fibrillation in Poland – Results of PolSenior study

“…Recent studies showed similar trends [22,23]. Stepinska et al described the baseline data from the GARFIELD-AF registry (an ongoing prospective, multicenter, international registry of patients newly diagnosed with AF) in Europe.…”